Funding opportunities
Grant handbook
A comprehensive collection of Breakthrough T1D’s grant mechanisms and descriptions; application guidelines and checklists; administrative resources; terms and conditions (updated July 2025); clinical resources; and contact information.
Open opportunities
Expand the opportunities below for deadlines and for application information. Download the Grant Handbook above for additional information.
Letters of Intent and Full Proposals are due by 5:00pm Eastern Time on the deadline date, unless otherwise noted.
Important: In a change from previous years, applicants proposing human subject research on long-term complications covered by the Breakthrough T1D research strategy (specifically diabetic eye, kidney, and cardiovascular disease) are eligible to apply for training awards. Human subject research includes interventional or observational trials as well as analysis of clinical bio-samples or data.
Letters of Intent due 29 Oct 2025
Apply Now
More Information
Participating Clinical Site Form
Letters of Intent due 5 Nov 2025
Apply Now
More Information
Letters of Intent due 12 Nov 2025
Apply Now
More Information
Informational Webinar and Q&A 30 October 2025 (12 p.m. ET)
Register Here
Letters of Intent due 17 Nov 2025
Apply Now
More Information
Letters of Intent due 4 Dec 2025
Apply Now
More Information
Informational Webinar and Q&A 16 Dec 2025 (11 a.m. ET)
Register Here
Letters of Intent due 7 Jan 2026
Apply Now
More Information
Full Proposals due 8 Jan 2026
Apply Now
More Information
Informational Webinar and Q&A 13 Jan 2026 (12 p.m. ET)
Register Here
Letters of Intent due 28 Jan 2026
Apply Now
More Information
Informational Webinar and Q&A 15 Jan 2026 (12 p.m. ET)
Register Here
Letters of Intent due 28 Jan 2026
Apply Now
More Information
A semi-annual submission for Strategic Research Agreement Letters of Intent that address Breakthrough T1D’s current Research Strategy.
Round 1
Letters of Intent due 6 Nov 2025
Notification by 18 Dec 2025
Round 2
Letters of Intent due 7 May 2026 (Apply Now)
Notification by 18 Jun 2026
A rolling submission for the institutional support of scientific meetings, conferences, and workshops relevant to the Breakthrough T1D mission. Individual conference attendance (personal registration fees, travel, etc.) is not supported.
Industry Discovery & Development Partnership
The Industry Discovery & Development Partnership (IDDP) Program provides funding to for-profit organizations conducting research projects that closely align with Breakthrough T1D’s priority research areas. The program combines the capabilities of for-profit entities in moving forward treatments and therapies with commercial potential, with Breakthrough T1D’s capabilities as the leading global T1D research and advocacy organization.
Refer to the IDDP Program Overview below for more information on aims and eligibility.
Breakthrough T1D welcomes inquiries from interested companies throughout the year. For questions or to express interest, please contact preaward@breakthrought1d.org.
RMS360 login
The research management system for Breakthrough T1D research applications, active awards, and peer-reviews.
